# N-acetyl Cysteine: the Effectiveness and Safety in a Cohort of Pediatric Patients With Chronic Kidney Disease

> **NCT04916080** · PHASE2 · COMPLETED · sponsor: **Beni-Suef University** · enrollment: 50 (actual)

## Conditions studied

- Chronic Kidney Diseases

## Interventions

- **DRUG:** N-acetyl cysteine

## Key facts

- **NCT ID:** NCT04916080
- **Lead sponsor:** Beni-Suef University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-01
- **Primary completion:** 2022-06-01
- **Final completion:** 2023-01-01
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2023-04-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04916080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04916080, "N-acetyl Cysteine: the Effectiveness and Safety in a Cohort of Pediatric Patients With Chronic Kidney Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04916080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*